07/28/2016 – Boston Scientific Corporation had its “buy” rating reiterated by analysts at Needham & Company. Boston Scientific Corporation makes up approx 0.07% of Daiwa Securities Group’s portfolio.First Quadrant L Pca boosted its stake in BSX in the latest quarter, The investment management firm added 14,100 additional shares and now holds a total of 42,600 shares of Boston Scientific Corporation which is valued at $1,033,476. Over the last 3 months and over the last 6 months, the shares of Boston Scientific Corporation (BSX), have changed 19.33% and 21.63%, respectively.
Advertisement
On the company’s financial health, Boston Scientific Corporation reported $0.27 EPS for the quarter, based on the information available during the earnings call on Jul 28, 2016. Boston Scientific Corporation makes up approx 0.08% of State Of Wisconsin Investment Board’s portfolio.Candriam Luxembourg S.c.a. reduced its stake in BSX by selling 205,076 shares or 80.08% in the most recent quarter. The market cap of Boston Scientific Corporation C was $32.23B after the equity closed at $23.510 in last trading day. The rating score is on a scale of 1 to 5 where 1 stands for strong buy and 5 stands for sell The mean price target for the shares of company is at $53.62 while the highest price target suggested by the analysts is $53.62 and low price target is $53.62. The firm has a SMA 50 (Simple Moving Average) of $24.04 and a SMA 200-(Simple Moving Average) of $21.63.
04/28/2016 – Boston Scientific Corporation had its “overweight” rating reiterated by analysts at Barclays. It has a profit margin of -4.30% that exhibits the company’s weekly performance at 0.83% *. Overweight rating was given by “0” and Underweight rating was given by “0”. During the same quarter in the previous year, the company posted $0.22 EPS.
The earnings per share growth rate for this year stands at -98.30% and 14.26% for the coming year.
On Friday, Shares of Boston Scientific Corporation (NYSE:BSX) lost -3.96% to $23.51. Analyst expected twelve month price target of $27.26. The share price of the stock plunged -10.79% for the year. For the prior quarter revenue for the stock hit $1.96B, with EPS at $0.28. Jefferies Group added BSX to its portfolio by purchasing 41,485 company shares during the most recent quarter which is valued at $991,077.
PG&E Corporation (NYSE:PCG)’s earnings per share growth ratio for the past 5 years was noted as -8.7% while revenue increase for the past 5 years was 4%.
Advertisement
Receive Boston Scientific Corporation News & Ratings Via Email – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Boston Scientific Corporation with MarketBeat.com’s FREE daily email newsletter. A year ago the company’s sales were $1.89B. The stock is a Buy among 22 brokerage firms polled by Factset Research.
